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Immune response (Ir) genes of the MHC are highly polymorphic and generally
control both the cellular and humoral responses to antigenic challenge (1). For class
I gene-encoded molecules, most ofthe polymorphic residues arelocated around the
proposed antigen binding site(2). Ahypothetical model ofclass II molecules predicts
that this site would be made up ofthe combined membrane-distal domains ofboth
a and a chains (3).
How does the extensive polymorphism displayed by MHC molecules affect their
function? In the absence of structural data for class II molecules, various groups
have proceeded to test either spontaneous (4) or selected (5-8) mutants of class II
encoded molecules for function in antigen presentation assays. In summary, the
findings imply that amino acid substitutions at positions scattered throughout the
membrane distal domains ofboth a and /3 chains can affect the presentation ofan-
tigen to T cells. However, in these studies, it was not always possible to distinguish
antigen binding from Tcell interaction defects. Here we report an analysis ofthe
presentation ofa single peptide epitope ofmyelin basic protein to a panel of MBP-
specific, I-A'-restricted T helper cell clones using cells expressing I-A' molecules
with mutations at defined residues of the /3 chain. The results show that the poly-
morphic regions of the I-A' /3 chain can accommodate a number of amino acid
changes without abrogating binding of this peptide. However, isolated substitution
ofamino acids inthese regionscan drastically alterthepatternofTcellclones capable
of interacting with the MHC/antigen complex.
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Materials and Methods
BriefDefinitive Report
T Cell Clones.
￿
The isolation ofT cell clones specific for the NH2-terminal nine amino
acids ofratMBP(rMBP) willbedescribedindetail elsewhere (Davis, C. B., et al. manuscript
submitted for publication). Briefly, T cells were isolated from two I-Ak mouse strains ofdis-
tinct genetic backgrounds, BIO.A(4R) and A/J, after immunization with a peptide corre-
sponding to the NH2-terminal eleven amino acids of rMBP. After three restimulations in
vitro, clones were isolated from one A/I cell line and one BIO.A(4R) cell line by sorting on
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the FAGS II flow cytometer, using propidium iodide and forward angle light scatter to select
only single viable cells In contrast to clones AJ1 .2 and 4R3.7, which are I-Ak restricted,
clones 4R3.9, 4R3.4, and 4R3 .6 respond to rMBP 1-16 presented by both I-Ak and I-A° ;
clones 4R3.4 and 4R3 .6 are also alloreactive on I-A°. None of the clones show antigen-
dependent or alloreactive responses to either I-Ad or I-As. We have not noted any distinc-
tion in either MHC recognition or peptide fine specificity to correlate with the genetic back-
ground from which the T cells were derived.
Antigen-presenting Cells.
￿
The cell lines used as APO for this study have been described in
detail elsewhere (9). Briefly, either wild-type a and /3 chains or site-directed mutants of the
/3 chain of I-Ak were transferred into an I-A J3 chain-negative variant of M12, M12 .C3 (10),
by electroporation. Transfected cell lines were appropriately selected and analyzed for cell
surface expression of wild-type or mutated I-A by quantitative immunofluorescence. All of
the mutant cell lines selected for this study (shown in Table I) stained equally as well as the
wild-type transfectant with either mAb 39B or 39J (9). Cells were maintained in culture in
RPMI 1640 medium (Gibco Laboratories, Grand Island, NY) supplemented with 10% heat-
inactivated FOS, 100 U/ml penicillin, 100 I~g/ml streptomycin, 2 MM L-glutamine, and 5 x
10-5 M 2-ME (RPMI/10).
T Cell Proliferation Assays.
￿
Transfected wild-type, mutant, and I-A- M12.C3 cells (5 x 106
to 107 cells/ml) were treated with mitomycin C (Sigma Chemical Co., St. Louis, MO) at 40
/Ag/ml in RPMI/10 for 40 min at 37'C. Cells were washed four times and plated at 2 x 104
cells per well in 96-well, flat-bottomed, microtiter plates. The synthetic peptide rMBP 1-16,
consisting of the acetylated NHz-terminal 16 amino acids of rMBP, was prepared as previ-
ously described (11) and added to give a final concentration of between 0 and 133 AM. T
cell clones were added at 2 x 104 cells per well in a final volume of0.2 ml of RPMI/10. After
48 h, [3H]thymidine was added at 1 uCi per well and cells were harvested 14-24h later. The
mean cpm of [3H]thymidine incorporation was calculated for triplicate measurements and
the standard deviations were <20% of the mean value. The experiments were repeated at
least two times for each T cell clone and APO cell line. Each result is displayed as the stimula-
tion index which is the cpm in the presence of antigen divided by cpm in the absence ofantigen.
Results and Discussion
From the hypothetical model of class II MHC molecules (3), the mutations used
for this study (Table I) would be predicted to fall on 0-strands forming part of the
floor or on an a-helix forming one wall of the proposed antigen binding cleft. Fig.
1 shows the results of an experiment in which three T cell clones were tested against
the mutant cell lines over a wide range of antigen concentration. Clone 4R3 .4
responded to peptide presented by mutants TC, TD, and T9, as well as the wild-type
TAk cell line. The mutant cell lines TB, T12, T14, and T.17 presented antigen
weakly, if at all, to clone 4R3.4. In contrast, mutant TC did not present antigen
to either clone 4R3.9 or AJ1.2. However, clone 4R3 .9 responded well to peptide
presented by T9, moderately to TD and significantly to T12, T14, and T17. Clone
AJ1 .2 responded well to antigen presented by TB, moderately to TD, but not
significantly to any of the other mutant cell lines.
Amino acid substitutions at positions 12 and 14 of the /3 chain caused a significant
reduction in the antigen presenting ability of the I-A molecule for all of the clones
tested. Previous studies had shown that the surface expression of mutated I-A on
T12 was slightly increased and T14 decreased (15-20%) when compared with the
wild-type transfectant (9). Cell line T12 presented antigen to clone 4R3.9 alone (Fig.
1) and only at a 28-fold higher concentration of peptide (44.3 /AM) than with the
wild-type TAk transfectant. These results suggest that residues 12 and 14 of the 0
chain may quantitatively affect peptide binding. A recent study has indicated that
residues 12 and 14 may also affect the binding of determinants recognized by al-DAVIS ET AL.
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TABLE I
Cell Lines Expressing ,B Chains with Single Amino Acid or Block
Substitutions and the Relationship of the Amino Acid Substitutions
to rMBP 1-11 Responder (H-2k and H-2u) and
Nonresponder Alleles (H-2d and H-2s)
' Amino acids are designated in the single-letter code.
l The predicted positions in the three-dimensional structure of I-A are from refer-
ence 3.
2241
loreactive T cells (12). Two ofthree I-Ak-specific hybridomas responded to cell lines
expressing an I-Aka chain with combined mutations in regions B, C, and D. How-
ever, neither hybridoma responded to cell lines T12 or T14.
Table II summarizes the proliferative responses offiveT cell clones. Data foreach
clone represent the peak response for each mutant APC in a single experiment and
are representative ofthe response patterns from at least two separate experiments.
All of the cell lines expressing mutated I-A molecules were able to present rMBP
1-16 to at least one of the T cell clones. T clones 4R3.4, 4R3.7, and 4R3.9 were
similar in their elevated response to peptide presented by cell line T9. However,
each clone displayed a unique response pattern. 4R3.4 responded to both mutants
T9 andTC, 4R3.7 respondedtoT9andTB, while 4R3.9did not respond significantly
to peptidepresented byeither TB orT.C. Clones AJ1.2 and4R3.6 have consistently
displayed an elevatedresponse to peptidepresented bycelllines T.B and T17, respec-
tively.
Substitution of histidine with valine at position 9 ofthe (3 chain resulted in im-
proved presentation to three of the five clones tested (Table II). For clones 4R3.4
and 4R3.9 there was an increase in stimulation index compared with the wild-type
TAk molecule, but there was not a significant shift in the dose-response curve (Fig.
1). This and the fact that clones AJ1.2 and 4R3.6 didnot show anincreasedresponse
to peptidepresented byT9 would argue against a straightforward effect ofthis sub-
stitution on peptide binding affinity. Even so, it is possible that changing histidine,
abasic residue, to valine, an uncharged hydrophobic residue, favors thebinding of
the basic rMBP 1-16 peptide.
How can the heterogeneity in response patterns of the different T cell clones be
explained? First, theresults couldindicate direct interaction ofparticular I-Aresidues
Cell line Residue H-2k H-2d H-2u H-2s
Predictedl
position
T.9 9 H'- V V F Strand 1
T.12 12 Q - K Q K Strand 1
T.14 14 F -" E F E Strand 1
T.17 17 F -+ Y F F Strand 1-2
T.B 63 K S K K
Helix 1-2
65 Y PEI Y Y
T.C 75 L V L V
Helix 2-3
78 V A V V
T.D 85 K G E G
86 T -" P T V Helix 3
89 P S P H2242
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FIGURE 1 . The proliferative
response ofrMBP peptide 1-9-
specific and I-Ak-restricted T
cell clones torMBP peptide 1-16
presented by wild-type (T.Ak)
and MHC-mutant cell lines .
Data are expressed as "stimula-
tion index" (meancpm incorpo-
ration in the presence divided by
mean cpm incorporation in the
absence of antigen) in order to
normalize for variation in back-
ground thymidine incorporation
by the APCs alone. Mean cpm
incorporation for2 x 104 APC
+ 2 x 104 clonedT cells, in the
absence of antigen, was calcu-
lated and is shownwith the stan-
dard deviation in parentheses :
T.Ak 5,981 (1,264) ; T.B, 3,338
(425) ; T.C, 1,973 (364) ; T.D =
9,644 (1,537); T.9 3,529 (705);
T.12, 10,234 (348) ; T.14, 3,118
(39.9) ; T.17, 1,360 (184). To
control for an effect of residual
feeder cells in theT cell cultures,
each T cell clonewas tested for
background proliferation with
133 AM rMBP 1-16 in the ab-
sence ofAPC. The ratio of re-
sponse with/without antigen for
4R3.4 was0.85, for clone4R3.9
was0.76, and for AJ1.2 was 1.82 .
with theTCR of isolated T cell clones. For example, Lys-63 and Tyr-65 could be
TCR interaction residues for 4R3.4, but not for AJ1.2 . The mutation in cell line
T.B substitutes theseresidues and would, according to this theory, affect recognition
by 4R3.4 and not AJ1.2 . Secondly, the amino acid substitutions in the mutated a
chains of cell lines T.9, TB, T.C, and T.D could alter the conformation of other
distantTCR interaction residues. Finally, since there maybe constraints on the con-
formation of peptides when bound toMHC molecules, it is conceivable that amino
acid substitutions in polymorphic residues of the I-A' 0 chain could affect the con-
formation ofbound peptide . In this way, amino acid substitutions in the I-A mole-
cule could alter the alignment ofTCR interaction residues in the peptide itself.
Our results are consistent with previous studies of class II-restricted responses
(4-8). In studying the presentation ofpeptides fromhen egg whitelysozyme or oval-DAVIS ET AL.
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TABLE II
Summary of the Response of RMBP Peptide 1-11-Specific T Cell Clones
to Peptide Presented by Wild-Type (TAk) andI-A' ,!I-Chain
Mutant Cell Lines
( -) 0-2 x stimulation index, ( t ) 2-5 x stimulation index, ( + ) 5-10 x stimulation index,
( + + ) 10-20 x stimulation index, and ( + + + ) >20 x stimulation index. These data represent
maximal stimulation indices for the range of antigen concentrations tested.
bumin, two groups have shown how mutations in the presenting I-A molecule can
affect the response of individual Tcell hybridomas withoutabolishing antigenbinding
(6, 7). Furthermore, implications from two other studies (4, 8) are that residue 29
of I-E/3 can be involved in antigen binding, while residues 67, 70, and 71 of I-A/3
are part ofacritical region forinteraction with theTCR. Assuming conformational
similarity between I-E and I-A molecules, and combining these data with our own
results, we anticipate that amino acid alterations from polymorphic regions 1 and
2, predicted to reside on strands 1 and 2 of the class II MHC /3 chain, may either
affect antigenbinding (8) oralterTCRinteractions (Table II, mutant T9). Changes
in residues from polymorphic regions 3 and 4, predicted to lie on the ci-helical, "ex-
posed" region of themolecule wouldbe more likely to affect TCRinteraction without
necessarily abolishing antigen binding (Table II, mutants TB, TC, and T.D).
Finally, it should be stressed that these studieshave largelyconcentrated on amino
acid substitutions in isolated regions of an MHC molecule. There is no doubt that
acombination of such substitutions can have amajor effect on peptide bindingand
thus on Ir gene phenomena(13). However, ourresults stress the importance ofpoly-
morphic residues in TCR interactions with an MHC-antigen complex at the level
of antigen presentation. By expression of mutant I-A molecules in transgenic mice
it will be possible to analyze the role of such polymorphic amino acids in thymic
selection of T cells specific for self antigens, such as MBP Such a study will have
direct bearing on those autoimmune diseases where a close association with class
II MHC alleles has been noted (14).
Summary
Proteins encoded by genesin the MHC arehighly polymorphic. Forclass II pro-
teins the highest level of polymorphism is found in distinct regions of variability,
notably in the membrane-distal domains. To investigate the role of such residues
in antigen presentation, we have tested cells transfected with wild-type or mutant
I-Al` /3 chains for their ability to present the NH2-terminal peptide of myelin basic
protein to a panel ofT cell clones. We were unable to detect a gross effect on peptide
binding, in that all of the mutant cell lines presented antigen to at least one of the
cloned T cells. However, the results imply that the more NH2-terminal residues,
particularly 12 and 14, areinvolved in peptideinteractions. Mutations at theseresidues
T clone T.Ak T.B T.C T.D
APC
T.9 T.12 T.14 T.17
4R3 .4 +++ - +++ ++ +++ t + +
4R3 .7 + ++ - - +++ - - -
4R3.9 + - t + +++ + + +
AJ1 .2 + +++ t + t - t -
4R3.6 + t - t - - + + +2244
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presented antigen only at high antigen concentrations. Furthermore, residues of the
more COOH-terminal regions appear to determine TCR interactions. Mutations
in the predicted cr-helical regions oftheachain affected antigen presentation without
abolishing peptide binding.
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